Diethyl Ether → 3-{2,6-Dimethyl-3-[3-methyl-5-(6-methyl-pyridin-2-yl)-thiophen-2-yl]-imidazo[1,2-b]pyridazin-8-yl}-pentan-3-ol
반응식
[CH3:1][C:2]1[N:3]=[C:4]2[C:9]([C:10](=[O:13])[CH2:11][CH3:12])=[CH:8][C:7]([CH3:14])=[N:6][N:5]2[C:15]=1[C:16]1[S:17][C:18]([C:22]2[CH:27]=[CH:26][CH:25]=[C:24]([CH3:28])[N:23]=2)=[CH:19][C:20]=1[CH3:21].[CH3:29][CH2:30]OCC.C([Mg]Br)C>CCOC(C)=O>[CH3:1][C:2]1[N:3]=[C:4]2[C:9]([C:10]([OH:13])([CH2:29][CH3:30])[CH2:11][CH3:12])=[CH:8][C:7]([CH3:14])=[N:6][N:5]2[C:15]=1[C:16]1[S:17][C:18]([C:22]2[CH:27]=[CH:26][CH:25]=[C:24]([CH3:28])[N:23]=2)=[CH:19][C:20]=1[CH3:21]참가 물질
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
To a −0° C. solution of 1-{2,6-dimethyl-3-[3-methyl-5-(6-methyl-pyridin-2-yl)-thiophen-2-yl]-imidazo[1,2-b]pyridazin-8-yl}-propan-1-one (0.040 g, 0.10 mmol) and Et2O (5 mL) is added 3.0 M ethyl magnesium bromide (0.68 mL, 2.05 mmol). The solution is warmed to ambient temperature, diluted with EtOAc (30 mL) washed with sat. NH4Cl (20 mL), dried over MgSO4, filtered and concentrated. The residue is purified by ISCO column chromatography (20%-30% EtOAc/hexane gradient) furnish the title compound (0.016 g, 0.038 mmol, 37%). 1H NMR (CDCl3), δ 0.89 (t, J=7.4 Hz, 6H), 1.92-2.01 (m, 4H), 2.14 (s, 3H), 2.46 (s, 3H), 2.53 (s, 3H), 3.57 (s, 3H), 6.39 (s, 1H), 6.66 (s, 1H), 7.01 (d, J=7.5 Hz, 1H), 7.46 (d, J=7.9 Hz, 1H), 7.52 (s, 1H), 7.57 (dd, J=7.9, 7.5 Hz, 1H). LC/MS (m/z): calcd. for C24H28N4OS (M+H)+: 421.3; found: 421.3.
후처리
- washwashed with sat. NH4Cl (20 mL)
- dry with materialdried over MgSO4
- filtrationfiltered
- concentrationconcentrated
- customThe residue is purified by ISCO column chromatography (20%-30% EtOAc/hexane gradient)
출처 및 근거
- ORD 기록
- ord-7643a38aa7884ffc887861b63c33124f
- 출처 데이터셋
- uspto-grants-2009_11
- 특허 번호
- US07612067B2
반응 노트
불러오는 중…